• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭管理中个性化医疗的兴起:一项叙述性综述

The Rise of Personalized Medicine in Heart Failure Management: A Narrative Review.

作者信息

Palaparthi Elizabeth Caroline, Aditya Reddy Palle, Padala Tanvi, Sri Venkata Mahi Karthika Kalahasthi, Paka Reshika, Ami Reddy Vignesh, Ayub Shirin, Khyati Sri Vanga, Rebanth Nandan Vubasaram, Patnaik Prashanth Kumar, Medabala Tambi, Sayana Suresh Babu

机构信息

Department of Internal Medicine, Shasta Regional Medical Center - Prime Healthcare, Redding, USA.

Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.

出版信息

Cureus. 2025 May 8;17(5):e83731. doi: 10.7759/cureus.83731. eCollection 2025 May.

DOI:10.7759/cureus.83731
PMID:40486428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12145133/
Abstract

Managing heart failure (HF) presents ongoing challenges due to the varied nature of the condition among individuals. Recent shifts toward personalized care aim to move beyond standard treatments by considering the unique characteristics of each patient. This review brings together current ideas and advancements that could shape a more tailored approach to HF, offering insights into how patient-specific strategies might improve the care. However, fully embracing this approach requires overcoming several hurdles to ensure these innovations are practical and widely available.

摘要

由于个体病情的多样性,心力衰竭(HF)的管理面临着持续的挑战。最近向个性化护理的转变旨在超越标准治疗,通过考虑每个患者的独特特征来实现。这篇综述汇集了当前可能塑造更具针对性的HF治疗方法的观点和进展,深入探讨了针对患者的策略如何改善护理。然而,要全面采用这种方法,需要克服几个障碍,以确保这些创新切实可行且广泛可用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feec/12145133/41da5b14f6ac/cureus-0017-00000083731-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feec/12145133/8dd1e8e4b507/cureus-0017-00000083731-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feec/12145133/41da5b14f6ac/cureus-0017-00000083731-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feec/12145133/8dd1e8e4b507/cureus-0017-00000083731-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feec/12145133/41da5b14f6ac/cureus-0017-00000083731-i02.jpg

相似文献

1
The Rise of Personalized Medicine in Heart Failure Management: A Narrative Review.心力衰竭管理中个性化医疗的兴起:一项叙述性综述
Cureus. 2025 May 8;17(5):e83731. doi: 10.7759/cureus.83731. eCollection 2025 May.
2
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure.超越利钠肽:揭示心力衰竭新兴生物标志物的力量。
Biomolecules. 2024 Mar 6;14(3):309. doi: 10.3390/biom14030309.
3
Emerging Therapeutic Strategies for Heart Failure: A Comprehensive Review of Novel Pharmacological and Molecular Targets.心力衰竭的新兴治疗策略:新型药理学和分子靶点的综合综述
Cureus. 2025 Apr 1;17(4):e81573. doi: 10.7759/cureus.81573. eCollection 2025 Apr.
4
Artificial Intelligence and Its Role in Diagnosing Heart Failure: A Narrative Review.人工智能及其在心力衰竭诊断中的作用:一篇叙述性综述。
Cureus. 2024 May 5;16(5):e59661. doi: 10.7759/cureus.59661. eCollection 2024 May.
5
Innovations in heart failure management: The role of cutting-edge biomarkers and multi-omics integration.心力衰竭管理的创新:前沿生物标志物和多组学整合的作用。
J Mol Cell Cardiol Plus. 2025 Mar 1;11:100290. doi: 10.1016/j.jmccpl.2025.100290. eCollection 2025 Mar.
6
Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives.变革个性化医疗:与多组学数据生成的协同作用、主要障碍及未来展望
Biomedicines. 2024 Nov 30;12(12):2750. doi: 10.3390/biomedicines12122750.
7
Digital Twins in Healthcare: Methodological Challenges and Opportunities.医疗保健中的数字孪生:方法学挑战与机遇
J Pers Med. 2023 Oct 23;13(10):1522. doi: 10.3390/jpm13101522.
8
Role of Artificial Intelligence and Personalized Medicine in Enhancing HIV Management and Treatment Outcomes.人工智能与个性化医疗在改善艾滋病病毒管理及治疗效果中的作用
Life (Basel). 2025 May 6;15(5):745. doi: 10.3390/life15050745.
9
Optimizing Treatment: The Role of Pharmacology, Genomics, and AI in Improving Patient Outcomes.优化治疗:药理学、基因组学和人工智能在改善患者治疗效果中的作用。
Drug Dev Res. 2025 May;86(3):e70093. doi: 10.1002/ddr.70093.
10
Advanced chronic kidney disease coexisting with heart failure: navigating patients' management.晚期慢性肾病合并心力衰竭:患者管理指南
Clin Kidney J. 2025 May 2;18(5):sfaf128. doi: 10.1093/ckj/sfaf128. eCollection 2025 May.

引用本文的文献

1
Biomarkers in Heart Failure: A Review and a Wish.心力衰竭中的生物标志物:综述与期望
Int J Mol Sci. 2025 Aug 20;26(16):8046. doi: 10.3390/ijms26168046.
2
Exploring the Role of Genetic and Genomic Factors in Therapeutic Response to Heart Failure: A Comprehensive Analytical Review.探索遗传和基因组因素在心力衰竭治疗反应中的作用:一项综合分析综述。
Genes (Basel). 2025 Jul 4;16(7):801. doi: 10.3390/genes16070801.

本文引用的文献

1
Emerging risk factors for heart failure in younger populations: A growing public health concern.年轻人群中心力衰竭的新兴风险因素:日益受到关注的公共卫生问题。
World J Cardiol. 2025 Apr 26;17(4):104717. doi: 10.4330/wjc.v17.i4.104717.
2
Remote monitoring and heart failure.远程监测与心力衰竭
Eur Heart J Suppl. 2025 Feb 19;27(Suppl 1):i126-i131. doi: 10.1093/eurheartjsupp/suae116. eCollection 2025 Feb.
3
Genetic Biomarkers in Heart Failure: From Gene Panels to Polygenic Risk Scores.心力衰竭的遗传生物标志物:从基因面板到多基因风险评分。
Curr Heart Fail Rep. 2024 Dec;21(6):554-569. doi: 10.1007/s11897-024-00687-5. Epub 2024 Oct 15.
4
A scoping review on advancements in noninvasive wearable technology for heart failure management.关于用于心力衰竭管理的无创可穿戴技术进展的范围综述。
NPJ Digit Med. 2024 Oct 12;7(1):279. doi: 10.1038/s41746-024-01268-5.
5
Personalized Heart Failure Management: Bridging Technology and Care.个性化心力衰竭管理:连接技术与护理
J Am Heart Assoc. 2024 Oct 15;13(20):e037648. doi: 10.1161/JAHA.124.037648. Epub 2024 Oct 11.
6
Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review.个性化框架下用于心血管疾病风险评估的人工智能:一项范围综述
EClinicalMedicine. 2024 May 27;73:102660. doi: 10.1016/j.eclinm.2024.102660. eCollection 2024 Jul.
7
Racial and Socioeconomic Determinants of Cardiovascular Health: A Comprehensive Review.心血管健康的种族和社会经济决定因素:一项综合综述。
Cureus. 2024 May 2;16(5):e59497. doi: 10.7759/cureus.59497. eCollection 2024 May.
8
Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review.心力衰竭早期检测中的新型生物标志物:一篇叙述性综述。
Cureus. 2024 Feb 2;16(2):e53445. doi: 10.7759/cureus.53445. eCollection 2024 Feb.
9
Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment.心血管治疗中的精准医学:药物治疗前评估药物遗传学分析的作用。
J Intern Med. 2024 May;295(5):583-598. doi: 10.1111/joim.13772. Epub 2024 Feb 11.
10
Application and Potential of Artificial Intelligence in Heart Failure: Past, Present, and Future.人工智能在心力衰竭中的应用与潜力:过去、现在与未来
Int J Heart Fail. 2023 Nov 30;6(1):11-19. doi: 10.36628/ijhf.2023.0050. eCollection 2024 Jan.